FDA Clearance Tracker · DEN220014
RefleXion Medical Radiotherapy System (RMRS)
Last checked: Nov 20, 2026Latest source record: Feb 1, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Feb 1, 2023
De Novo granted
Time to decision
343 days
Received Feb 23, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN220014
- Device name
- RefleXion Medical Radiotherapy System (RMRS)
- Applicant
- Reflexion Medical, Inc.
- Applicant location
- Hayward, CA
- Received
- Feb 23, 2022
- Decided
- Feb 1, 2023
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 892.5060
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for DEN220014
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Reflexion Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252071 · Decided Dec 18, 2025 · 170 days after receipt
Device type: Fludeoxyglucose F18-Guided Radiation Therapy System (QVA) · Radiology & Imaging
K190978 · Decided Mar 12, 2020 · 332 days after receipt
Device type: Accelerator, Linear, Medical (IYE) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.